Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells.

NF-kappaB/Rel is a family of transcription factors which are expressed in all cells; however, in most non-B cells, they are sequestered in the cytoplasm in inactive complexes with specific inhibitory proteins, termed IkappaBs. We have recently shown that NF-kappaB/Rel factors are aberrantly activated in human breast cancer and rodent mammary tumors, and function to promote tumor cell survival and proliferation. Here, we have examined the time-course of induction of NF-kappaB/Rel factors upon carcinogen treatment of female Sprague-Dawley (S-D) rats in vivo and in human mammary epithelial cells (HMECs) in culture. We observed that NF-kappaB/Rel activation is an early event, occurring prior to malignant transformation. In S-D rats, increased NF-kappaB/Rel binding was detected in nuclear extracts of mammary glands from 40% of animals 3 weeks post-treatment with 15 mg/kg 7,12-dimethylbenz[a]anthracene (DMBA); this is prior to formation of tumors which normally begin to be detected after 7-9 weeks. In non-tumorigenic MCF-10F cells, in vitro malignant transformation upon treatment with either DMBA or benzo[a]pyrene (B[a]P) resulted in a 4- to 12-fold increase in activity of classical NF-kappaB (p65/p50). NF-kappaB induction was corrrelated with a decrease in the stability of the NF-kappaB-specific inhibitory protein IkappaB-alpha. Ectopic expression of the transactivating p65 subunit of NF-kappaB in MCF-10F cells induced the c-myc oncogene promoter, which is driven by two NF-kappaB elements, and endogenous c-Myc levels. Furthermore, reduction mammoplasty-derived HMECs, immortalized following B[a]P exposure, showed dysregulated induction of classical NF-kappaB prior to malignant transformation. Together these findings suggest that activation of NF-kappaB plays an early, critical role in the carcinogen-driven transformation of mammary glands.

[1]  A. Miyajima,et al.  An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells. , 1999, The Journal of urology.

[2]  Q. Khan,et al.  DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens (review). , 1999, International journal of oncology.

[3]  J. Russo,et al.  Biological and molecular basis of human breast cancer. , 1998, Frontiers in bioscience : a journal and virtual library.

[4]  R. Hay,et al.  Defective IκBα in Hodgkin cell lines with constitutively active NF-κB , 1998, Oncogene.

[5]  E. Thompson,et al.  The many roles of c-Myc in apoptosis. , 1998, Annual review of physiology.

[6]  A. E. Rogers,et al.  Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.

[7]  P. Yaswen,et al.  Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells. , 1997, Molecular biology of the cell.

[8]  M. P. Miano,et al.  Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression , 1997, Oncogene.

[9]  G. Sonenshein,et al.  Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes. , 1997, The American journal of pathology.

[10]  M. Arsura,et al.  Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[11]  G. Sonenshein.  Rel/NF-κB transcription factors and the control of apoptosis , 1997 .

[12]  Céline Gélinas,et al.  Rel/NF-?B and I?B factors in oncogenesis , 1997 .

[13]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[14]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[15]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.

[16]  Michael Karin,et al.  Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.

[17]  M. Arsura,et al.  Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells , 1996, Molecular and cellular biology.

[18]  B. Dörken,et al.  High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. , 1996, Blood.

[19]  R. Taub.  Transcriptional control of liver regeneration , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  G. Sonenshein,et al.  Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. , 1995, The Journal of clinical investigation.

[21]  David Baltimore,et al.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.

[22]  D. Kelleher,et al.  Cellular Proliferation and Activation of NFκB Are Induced by Autocrine Production of Tumor Necrosis Factor α in the Human T Lymphoma Line HuT 78 (*) , 1995, The Journal of Biological Chemistry.

[23]  F. A. La Rosa,et al.  Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors , 1994, Molecular and cellular biology.

[24]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.

[25]  P. Yaswen,et al.  Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle. , 1993, Experimental cell research.

[26]  N Dubin,et al.  Blood levels of organochlorine residues and risk of breast cancer. , 1993, Journal of the National Cancer Institute.

[27]  J. Russo,et al.  Transformation of human breast epithelial cells by chemical carcinogens. , 1993, Carcinogenesis.

[28]  P. Yaswen,et al.  Culture systems for study of human mammary epithelial cell proliferation, differentiation and transformation. , 1993, Cancer surveys.

[29]  E. Seifter,et al.  The role of aromatic hydrocarbons in the genesis of breast cancer. , 1992, Medical hypotheses.

[30]  J. Godbold,et al.  Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. , 1992, Archives of environmental health.

[31]  D. Flesch‐Janys,et al.  Cancer mortality among workers in chemical plant contaminated with dioxin , 1991, The Lancet.

[32]  H. Preisler,et al.  Evaluation of c-myc proto-oncogene in primary human breast carcinomas. , 1991, Anticancer research.

[33]  H. Clevers,et al.  Identification and cloning of TCF‐1, a T lymphocyte‐specific transcription factor containing a sequence‐specific HMG box. , 1991, The EMBO journal.

[34]  A. E. Rogers,et al.  Dimethylbenzanthracene-induced mammary tumorigenesis in ethanol-fed rats. , 1990 .

[35]  G. Sonenshein,et al.  Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  W. Willett.  The search for the causes of breast and colon cancer , 1989, Nature.

[37]  H. E. Gray,et al.  Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation , 1984, Cell.

[38]  A. Dean,et al.  Cancer rates in a community exposed to low levels of creosote components in municipal water. , 1980, Minnesota medicine.

[39]  E. L. Springer,et al.  Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. , 1977, Journal of the National Cancer Institute.

[40]  L. Tomatis,et al.  Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue , 1976, Bulletin of environmental contamination and toxicology.